COVID-19 Respiratory Monitoring with MediPines AGM100? in Long-Term Care Facilities
ORANGE COUNTY, Calif.,?Oct. 22, 2020?/PRNewswire/ --?Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a respiratory medical device company, has released a?scientific paper?on respiratory monitoring in long-term care facilities.
The CDC recommends frequent respiratory monitoring of long-term care residents, who are disproportionally impacted by COVID-19. The use of a portable, non-invasive respiratory monitoring system that detects pulmonary gas exchange impairment, like the?MediPines AGM100?, is proving valuable in monitoring the elderly and those who are high-risk.
"We were concerned about the practicality of frequent respiratory monitoring in our elderly residents, and the presence of unpredictable conditions like silent hypoxemia. As a result, we committed to using an advanced respiratory monitoring system [AGM100] to obtain residents' gas exchange measurements. We are monitoring both residents and staff to establish a baseline respiratory measurement. By doing this we will recognize if there is any change in a resident's or staff's respiratory status, giving us an early indication of potentially harmful respiratory conditions (e.g., Covid)," stated?Jon Howell, Co-Owner of Gracious Living Estates in?Pennsylvania.
"Unfortunately, respiratory illnesses like COVID-19, are disproportionally impacting our elderly population. There is an urgent need for frequent respiratory monitoring in this at-risk population," said?Steve Lee, CEO of MediPines.
In an effort to support long-term care residents and workers, MediPines has released a scientific paper outlining the medical rationale behind proper respiratory monitoring. The discussion outlines the use of a non-invasive respiratory assessment for residents who may not be exhibiting classical symptoms (i.e. low oxygen saturation), but still may be suffering from lung damage due to COVID-19, such as "silent hypoxemia." The MediPines AGM100??is a respiratory monitoring system that provides rapid non-invasive pulmonary gas exchange measurements, typically in under two minutes.
See MediPines Scientific Series: "The Case for Respiratory Monitoring in Long-Term Care Facilities: COVID-19"
MediPines AGM100???
MediPines AGM100??is?an advanced respiratory monitoring?system?that provides a?comprehensive?respiratory assessment?designed to support medical providers?with?rapid detection of?respiratory?impairment.?MediPines AGM100??is an FDA cleared technology that non-invasively provides medical grade?pulmonary gas exchange measurements. The device has been clinically validated and is FDA cleared and authorized for COVID-19 emergency use by Health Canada. About MediPines
MediPines Corporation is?a market leader in respiratory?assessment and?monitoring?of?pulmonary?gas exchange.??Our mission is to advance respiratory medicine by providing physiology-based, respiratory devices that empower healthcare providers?to advance?the?effectiveness?and operating efficiency of?patient?care. To learn more about MediPines visit:?medipines.com Contact MediPines:
Carissa Drews
(949) 398-4670
info@medipines.com SOURCE MediPines
MediPines AGM100??is?an advanced respiratory monitoring?system?that provides a?comprehensive?respiratory assessment?designed to support medical providers?with?rapid detection of?respiratory?impairment.?MediPines AGM100??is an FDA cleared technology that non-invasively provides medical grade?pulmonary gas exchange measurements. The device has been clinically validated and is FDA cleared and authorized for COVID-19 emergency use by Health Canada. About MediPines
MediPines Corporation is?a market leader in respiratory?assessment and?monitoring?of?pulmonary?gas exchange.??Our mission is to advance respiratory medicine by providing physiology-based, respiratory devices that empower healthcare providers?to advance?the?effectiveness?and operating efficiency of?patient?care. To learn more about MediPines visit:?medipines.com Contact MediPines:
Carissa Drews
(949) 398-4670
info@medipines.com SOURCE MediPines
